Effect of Levosimendan on Ventricular Remodelling in Patients with Left Ventricular Systolic Dysfunction: A Meta-Analysis
Journal: ESC Heart Failure
Year: 2024

Heart failure is the final stage of several cardiovascular diseases, and the key to effectively treating heart failure is to reverse or delay ventricular remodelling. Levosimendan is a novel inotropic and vasodilator agent used in heart failure, whereas the impact of levosimendan on ventricular remodelling is still unclear. This study aims to investigate the impact of levosimendan on ventricular remodelling in patients with left ventricular systolic dysfunction. Electronic databases were searche